urea has been researched along with Abdominal Migraine in 23 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| " For hemicrania we used cinnarizine, cyproheptadine, clonidine, histamine, pizotifene and reserpine; for cluster headache, cinnarizine, cyproheptadine, clonidine, histamine and reserpine; for tension headache, cyproheptadine; for psychogenic headache, allylpropylmalonylurea." | 5.04 | [Therapeutic possibilities in idiopathic headaches. Analysis of 1000 cases (author's transl)]. ( Agostoni, A; Brandi, G; Cottino, A; Gai, V; Gastaldi, L; Lisino, F; Nattero, G, 1975) |
| " The global incidence of adverse events was 45% higher with EC, though not significant (32 vs." | 2.69 | Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks. ( Geraud, G; Gómez, JP; Henry, P; Joffroy, A; Lainez, JM; Le Jeunne, C; Liaño, H; Pradalier, A; Titus i Albareda, F, 1999) |
| " By measuring the brain function using computer period analysis of cerebral biopotentials, dose-efficacy relations were found (in the range of 25-75 mcg) which suggest the bioavailability of LHM at the CNS level." | 2.64 | Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram. ( Akpinar, S; Herrmann, WM; Itil, TM, 1975) |
| "A rat model of migraine induced by recurrent administration of nitroglycerin (NTG) (5 mg/kg/i." | 1.62 | The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats. ( Abbasnejad, M; Esmaeili-Mahani, S; Kooshki, R; Pourrahimi, AM; Raoof, M, 2021) |
| "The NTG-induced migraine symptoms were recorded for 90 min." | 1.62 | Orexin one receptors within the basolateral amygdala are involved in the modulation of cognitive deficits associated with a migraine-like state in rats. ( Abbasnejad, M; Askari-Zahabi, K; Esmaeili-Mahani, S; Kooshki, R, 2021) |
| "To model chronic migraine-associated pain, nitroglycerin (NTG) (5 mg/kg/IP) was administered to test subjects every second day for 9 days." | 1.56 | Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats. ( Abbasnejad, M; Esmaeili-Mahani, S; Kooshki, R; Raoof, M; Sheibani, V, 2020) |
| "This sensitisation reached a maximum in 60-90 min, at which time responses had risen to approximately twice that of control levels seen before the application of inflammatory soup." | 1.35 | The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission. ( Appleby, JM; Chizh, BA; Davis, JB; Hoskin, KL; Lambert, GA; Zagami, AS, 2009) |
| " The therapeutic cycles were standardized, for each drug, in the way of administration, dosage and total duration of the treatment." | 1.26 | [Therapeutic possibilities in idiopathic headaches. Analysis of about 1000 cases]. ( Agostoni, A; Brandi, G; Cottino, A; Gai, V; Gastaldi, L; Lisino, F; Nattero, G, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (73.91) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Pourrahimi, AM | 1 |
| Abbasnejad, M | 3 |
| Raoof, M | 2 |
| Esmaeili-Mahani, S | 3 |
| Kooshki, R | 3 |
| Sheibani, V | 1 |
| Askari-Zahabi, K | 1 |
| Joshi, P | 1 |
| Anderson, C | 1 |
| Binch, H | 1 |
| Hadida, S | 1 |
| Yoo, S | 1 |
| Bergeron, D | 1 |
| Decker, C | 1 |
| terHaar, E | 1 |
| Moore, J | 1 |
| Garcia-Guzman, M | 1 |
| Termin, A | 1 |
| Lambert, GA | 1 |
| Davis, JB | 1 |
| Appleby, JM | 1 |
| Chizh, BA | 1 |
| Hoskin, KL | 1 |
| Zagami, AS | 1 |
| MEAD, BJ | 1 |
| Le Jeunne, C | 1 |
| Gómez, JP | 1 |
| Pradalier, A | 1 |
| Titus i Albareda, F | 1 |
| Joffroy, A | 1 |
| Liaño, H | 1 |
| Henry, P | 1 |
| Lainez, JM | 1 |
| Geraud, G | 1 |
| Herrmann, WM | 3 |
| Horowski, R | 1 |
| Dannehl, K | 1 |
| Kramer, U | 1 |
| Lurati, K | 1 |
| Somerville, BW | 1 |
| Matevosian, AA | 1 |
| Nattero, G | 2 |
| Agostoni, A | 2 |
| Brandi, G | 2 |
| Cottino, A | 2 |
| Gai, V | 2 |
| Gastaldi, L | 2 |
| Lisino, F | 2 |
| Itil, TM | 2 |
| Akpinar, S | 2 |
| Herrmann, W | 1 |
| Dufresne, JJ | 1 |
| Muggler, J | 1 |
| Probst, C | 1 |
| Lance, JW | 2 |
| Anthony, M | 2 |
| Ripka, O | 1 |
| Paskova, Z | 1 |
| Hodek, B | 1 |
| Miklikova, Z | 1 |
| Whitty, CW | 1 |
| Podvalová, I | 1 |
| Dlabac, A | 1 |
| Somerville, B | 1 |
| Law, FW | 1 |
9 trials available for urea and Abdominal Migraine
| Article | Year |
|---|---|
Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Analgesics; Aspirin; Caffeine; Double-Blind Method; Drug Th | 1999 |
Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergide.
Topics: Adult; Clinical Trials as Topic; Ergolines; Female; Humans; Male; Maleates; Methysergide; Middle Age | 1977 |
Migraine prophylaxis with Lisuride hydrogen maleate--a double blind study of Lisuride versus placebo.
Topics: Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Ergolines; Humans; Migraine Disorder | 1978 |
[Comparative evaluation of the new antiserotonin preparations, sandomigran and lizenil, in treating patients suffering from migraine].
Topics: Adult; Cerebrovascular Circulation; Chronic Disease; Clinical Trials as Topic; Czechoslovakia; Drug | 1976 |
[Therapeutic possibilities in idiopathic headaches. Analysis of 1000 cases (author's transl)].
Topics: Aspirin; Caffeine; Cinnarizine; Clinical Trials as Topic; Clonidine; Cyproheptadine; Drug Therapy, C | 1975 |
Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram.
Topics: Adolescent; Adult; Aged; Biological Availability; Child; Child, Preschool; Clinical Trials as Topic; | 1975 |
[Trials with the new preparation cephatac in the attack treatment of migraine (author's transl)].
Topics: Capsules; Complex Mixtures; Drug Combinations; Drug Evaluation; Ergotamines; Humans; Lactones; Migra | 1975 |
[Treatment of 30 patients with HH 232 (author's transl)].
Topics: Analgesics; Clinical Trials as Topic; Complex Mixtures; Drug Evaluation; Ergotamines; Female; Humans | 1974 |
A comparative trial of serotonin antagonists in the management of migraine.
Topics: Clinical Trials as Topic; Cyproheptadine; Ergolines; Humans; Methysergide; Migraine Disorders; Pheno | 1970 |
14 other studies available for urea and Abdominal Migraine
| Article | Year |
|---|---|
The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats.
Topics: Animals; Anxiety; Behavior, Animal; Benzoxazoles; Male; Migraine Disorders; Naphthyridines; Orexin R | 2021 |
Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats.
Topics: Animals; Benzoxazoles; Calcitonin Gene-Related Peptide; Male; Microinjections; Migraine Disorders; N | 2020 |
Orexin one receptors within the basolateral amygdala are involved in the modulation of cognitive deficits associated with a migraine-like state in rats.
Topics: Animals; Basolateral Nuclear Complex; Benzoxazoles; Cognitive Dysfunction; Male; Migraine Disorders; | 2021 |
Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Dipeptides; Humans; Imidazoles; Inhibitory Conce | 2014 |
The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission.
Topics: Analgesics; Animals; Blood Pressure; Cats; Cerebrovascular Circulation; Disease Models, Animal; Dura | 2009 |
UREA IN THE TREATMENT OF MIGRAINE.
Topics: Biomedical Research; Drug Therapy; Humans; Migraine Disorders; Urea | 1964 |
[Therapeutic possibilities in idiopathic headaches. Analysis of about 1000 cases].
Topics: Cinnarizine; Clonidine; Cyproheptadine; Headache; Histamine; Humans; Methysergide; Migraine Disorder | 1976 |
Discovery of "specific" CNS effects of lisuride hydrogen maleate--an antimigraine compound.
Topics: Brain; Depression, Chemical; Electroencephalography; Ergolines; Humans; Migraine Disorders; Urea | 1975 |
[Effects of a long-term administration on an antiserotonin agent, Lysenyl, in headaches of different origins].
Topics: Adult; Aged; Cerebrovascular Disorders; Ergolines; Erythrocytes; Female; Giant Cell Arteritis; Heada | 1972 |
[Experience with Lysenyl in allergology].
Topics: Adolescent; Adult; Aged; Asthma; Child; Chronic Disease; Conjunctivitis; Eczema; Ergolines; Female; | 1972 |
The aetiology of migraine.
Topics: Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Migraine Disorders; Urea | 1970 |
Lysenyl, a new antiserotonin agent. Pharmacological and clinical survey.
Topics: Animals; Antihypertensive Agents; Behavior, Animal; Blood Pressure; Dose-Response Relationship, Drug | 1970 |
Thermographic, hormonal, and clinical studies in migraine.
Topics: Body Temperature; Cycloheptanes; Cyproheptadine; Ergolines; Female; Humans; Menstruation; Methysergi | 1970 |
Migraine research.
Topics: Asthenopia; Humans; Migraine Disorders; Refractive Errors; Urea | 1971 |